γδTDEs: An Efficient Delivery System for miR-138 with Anti-tumoral and Immunostimulatory Roles on Oral Squamous Cell Carcinoma
2018 · Molecular Therapy — Nucleic Acids · 71 citations
https://doi.org/10.1016/j.omtn.2018.11.009
B
Bangrong Cao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
1.3K
Citations
18
h-index
28
i10-index
Bangrong Cao is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Esophageal Cancer Research and Treatment & Extracellular vesicles in disease & MicroRNA in disease regulation. The author has an h-index of 18, co-authored 56 publications.
ORCID: 0000-0002-3865-3563Papers by this author
worksAn novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma
2011 · Journal of Translational Medicine · 68 citations
https://doi.org/10.1186/1479-5876-9-157
Small extracellular vesicles containing miR-192/215 mediate hypoxia-induced cancer-associated fibroblast development in head and neck squamous cell carcinoma
2021 · Cancer Letters · 47 citations
https://doi.org/10.1016/j.canlet.2021.01.006
Selection of a novel DNA thioaptamer against HER2 structure
2015 · Clinical & Translational Oncology · 23 citations
https://doi.org/10.1007/s12094-015-1292-0
A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer
2017 · BMC Cancer · 17 citations
https://doi.org/10.1186/s12885-017-3821-4
Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial
2024 · Nature Communications · 17 citations
https://doi.org/10.1038/s41467-024-51105-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat